Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation.
Yoshimura A, Yamada T, Okura N, Takeda T, Hirose K, Kubota Y, Shiotsu S, Hiranuma O, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K.
Yoshimura A, et al. Among authors: kaneko y.
Cancers (Basel). 2019 Mar 15;11(3):365. doi: 10.3390/cancers11030365.
Cancers (Basel). 2019.
PMID: 30875919
Free PMC article.